HEARTBEAM INC BEATW
*W EXP 10/31/202 · Equity WRT · CUSIP 42238H116
- SectorHealth care
- IndustrySurgical & Medical Instruments & Apparatus
- HeadquartersSanta Clara, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.20.
Trends to Q3 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 8 |
| Q4 2022 | 8 |
| Q1 2023 | 7 |
| Q2 2023 | 7 |
| Q3 2023 | 8 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 2 | 3 |
| Q1 2023 | 1 | 3 |
| Q2 2023 | 0 | 4 |
| Q3 2023 | 2 | 3 |
Biggest buyers
| UBS Group AG | New | +7.7k |
| BANK OF AMERICA CORP /DE/ | New | +200 |
Biggest sellers
| SABBY MANAGEMENT, LLC | Sold out | -17.9k |
| Warberg Asset Management LLC | Reduced | -4.5k |
| CLEAR STREET LLC | Reduced | -200 |
Insider purchases and sales in Q3 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2021 | 2 | $100.7k | 0 | — | — |
| Q1 2022 | 0 | — | 0 | — | — |
| Q2 2022 | 0 | — | 0 | — | — |
| Q3 2022 | 0 | — | 0 | — | — |
| Q4 2022 | 0 | — | 0 | — | — |
| Q1 2023 | 0 | — | 0 | — | — |
| Q2 2023 | 0 | — | 0 | — | — |
| Q3 2023 | 0 | — | 1 | $92.9k | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2023-09-29 | de Urioste George Director | Sold | $11.3k5.5k shares |
| 2023-09-28 | de Urioste George Director | Sold | $16.3k8.0k shares |
| 2023-09-27 | de Urioste George Director | Sold | $3.9k1.8k shares |
| 2023-09-26 | de Urioste George Director | Sold | $10.4k5.0k shares |
| 2023-09-22 | de Urioste George Director | Sold | $5.3k2.4k shares |
| 2023-09-21 | de Urioste George Director | Sold | $241100 shares |
| 2023-09-20 | de Urioste George Director | Sold | $2.2k883 shares |
| 2023-09-18 | de Urioste George Director | Sold | $12.3k5.0k shares |
| 2023-09-15 | de Urioste George Director | Sold | $10.4k4.3k shares |
| 2023-09-14 | de Urioste George Director | Sold | $10.8k5.0k shares |
| 2023-09-13 | de Urioste George Director | Sold | $9.7k5.0k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q3 2023
| Manager | Shares | Change |
|---|---|---|
| ARMISTICE CAPITAL, LLC 0.00% of their portfolio | 500.0k $100.0k | Unchanged |
| Warberg Asset Management LLC 0.00% of their portfolio | 58.3k $11.7k | Reduced -4.5k |
| Ayrton Capital LLC 0.07% of their portfolio | 50.0k $10.0k | Unchanged |
| UBS Group AG 0.00% of their portfolio | 7.7k $1.5k | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 7.5k $1.5k | Unchanged |
| CLEAR STREET LLC 0.00% of their portfolio | 1.8k $356 | Reduced -200 |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 200 $40 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |